Profile data is unavailable for this security.
About the company
PT Soho Global Health Tbk is an Indonesia-based company. The Company operates in the healthcare sector. The Company operates through five segments: Distribution, Professional product, Consumer health, Alliance, and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. The Company's product portfolio ranged from wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics.
- Revenue in IDR (TTM)8.58tn
- Net income in IDR440.54bn
- Incorporated--
- Employees2.32k
- LocationSoho Global Health Tbk PTJalan Jend. Sudirman Kav 27Mayapada 2 Building, 12th FloorJakarta 12920IndonesiaIDN
- Phone+62 2 146832588
- Fax+62 2 146832589
- Websitehttps://sohoglobalhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chengdu Olymvax Biopharmaceuticals Inc | 1.12tn | -27.62bn | 7.98tn | 471.00 | -- | 3.96 | -- | 7.10 | -0.0303 | -0.0303 | 1.23 | 2.21 | 0.3338 | 0.4197 | 1.08 | 1,061,669.00 | -1.22 | 3.17 | -1.70 | 4.68 | 93.29 | 93.00 | -3.64 | 7.44 | 1.92 | -3.90 | 0.2505 | 9.82 | -9.38 | 45.40 | -33.94 | -- | 56.47 | -- |
Clinuvel Pharmaceuticals Limited | 931.20bn | 321.68bn | 8.00tn | 16.00 | 25.72 | 4.20 | 24.09 | 8.59 | 0.5825 | 0.5825 | 1.69 | 3.56 | 0.4693 | -0.9514 | 7.35 | -- | 16.21 | 21.25 | 18.57 | 23.55 | 109.28 | -- | 34.54 | 41.84 | 6.43 | 14.53 | 0.006 | 7.44 | 24.27 | 26.14 | 46.58 | 18.27 | 68.74 | 20.11 |
Medincell SA | 191.87bn | -467.37bn | 8.01tn | 138.00 | -- | -- | -- | 41.73 | -1.02 | -1.02 | 0.4086 | -0.8965 | 0.2605 | -- | 6.81 | -- | -63.46 | -- | -115.15 | -- | 60.43 | -- | -243.58 | -366.40 | -- | -4.29 | 1.69 | -- | -8.67 | 44.33 | 21.78 | -- | -- | -- |
Theravance Biopharma Inc | 1.00tn | -729.29bn | 8.12tn | 99.00 | -- | 2.43 | -- | 8.10 | -0.861 | -0.861 | 1.19 | 4.22 | 0.1352 | -- | 4.57 | 621,313.10 | -9.84 | -40.51 | -10.39 | -48.50 | -- | -- | -72.78 | -305.27 | -- | -- | 0.00 | -- | 11.84 | -0.9956 | 40.54 | -- | -19.24 | -- |
Eyepoint Pharmaceuticals Inc | 814.81bn | -1.29tn | 8.24tn | 121.00 | -- | 1.94 | -- | 10.11 | -1.83 | -1.83 | 1.17 | 5.01 | 0.2068 | 1.14 | 7.44 | 413,380.20 | -32.62 | -40.44 | -40.06 | -47.79 | 90.50 | 83.45 | -157.77 | -186.23 | 5.01 | -- | 0.00 | -- | 11.14 | -- | 30.77 | -- | -- | -- |
Pharmanutra SpA | 1.77tn | 191.54bn | 8.27tn | 111.00 | 42.78 | 8.15 | 34.21 | 4.66 | 1.13 | 1.13 | 10.43 | 5.93 | 0.9123 | 0.5233 | 4.00 | 955,428.60 | 9.85 | 18.39 | 13.20 | 24.80 | 95.92 | 96.36 | 10.79 | 17.77 | 1.87 | 34.93 | 0.3324 | 52.51 | 21.13 | 16.51 | -14.73 | 8.44 | 75.71 | 11.20 |
Beijing Konruns Pharmaceutical Co Ltd | 2.14tn | 373.91bn | 8.34tn | 447.00 | 21.89 | 1.17 | -- | 3.89 | 1.06 | 1.06 | 6.05 | 19.78 | 0.2548 | 2.50 | 3.73 | 2,134,547.00 | 5.46 | 5.43 | 6.39 | 6.24 | 88.29 | 89.93 | 21.44 | 20.76 | 3.08 | -- | 0.0486 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
Jiangsu Aidea Pharmaceutical Co Ltd | 879.84bn | -202.56bn | 8.36tn | 476.00 | -- | 3.34 | -- | 9.50 | -0.2106 | -0.2106 | 0.9303 | 2.65 | 0.227 | 1.23 | 1.98 | 822,765.80 | -5.23 | -2.40 | -7.18 | -2.85 | 44.46 | 39.00 | -23.02 | -10.15 | 1.20 | -- | 0.2992 | -- | 68.44 | 8.24 | 38.75 | -- | -4.47 | -- |
Soho Global Health Tbk PT | 8.58tn | 440.54bn | 8.38tn | 2.32k | 19.01 | 3.32 | 16.46 | 0.9758 | 34.71 | 34.71 | 676.37 | 198.99 | 1.77 | 5.67 | 4.97 | 3,617,495,000.00 | 9.06 | 7.97 | 16.53 | 14.37 | 16.24 | 19.39 | 5.13 | 4.65 | 1.26 | -- | 0.006 | -- | 12.45 | 12.43 | 4.10 | 49.70 | 21.21 | -- |
Shanghai New World Co Ltd | 2.57tn | 75.47bn | 8.39tn | 1.20k | 111.13 | 0.8879 | -- | 3.26 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |